Literature DB >> 17297469

Hypermethylation of Ron proximal promoter associates with lack of full-length Ron and transcription of oncogenic short-Ron from an internal promoter.

D Angeloni1, A Danilkovitch-Miagkova, T Ivanova, E Braga, E Zabarovsky, M I Lerman.   

Abstract

The gene for tyrosine-kinase receptor Ron (MST1R) resides in the chromosome 3p21.3 region, frequently affected in common human malignancies. The gene generates two transcripts, 5 and 2 kb-long, full-length Ron (flRon) and short-form Ron (sfRon), respectively. Here, we show for the first time that the variegated Ron expression is associated with variations in the methylation patterns of two distinct CpG islands in Ron proximal promoter. Widespread hypermethylation associates with lack of flRon whereas hypermethylation of the distal island associates with transcription of sfRon, a constitutively active tyrosine-kinase that drives cell proliferation. sfRon inhibition with kinase-dead transgenes decreases cancer cell growth and induces cellular differentiation. sfRon could be a new drug target in cancer types in which it contributes to tumor progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17297469     DOI: 10.1038/sj.onc.1210238

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

1.  The tyrosine kinase sf-Stk and its downstream signals are required for maintenance of friend spleen focus-forming virus-induced fibroblast transformation.

Authors:  Tanya M Jelacic; Delores Thompson; Charlotte Hanson; Joan L Cmarik; Kazuo Nishigaki; Sandra Ruscetti
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

2.  Short-form RON overexpression augments benzyl isothiocyanate-induced apoptosis in human breast cancer cells.

Authors:  Anuradha Sehrawat; Shivendra V Singh
Journal:  Mol Carcinog       Date:  2015-04-07       Impact factor: 4.784

3.  Short-Form Ron Promotes Spontaneous Breast Cancer Metastasis through Interaction with Phosphoinositide 3-Kinase.

Authors:  Xuemei Liu; Ling Zhao; Yoko S Derose; Yi-Chun Lin; Magdalena Bieniasz; Henok Eyob; Saundra S Buys; Leigh Neumayer; Alana L Welm
Journal:  Genes Cancer       Date:  2011-07

4.  Prognostic significance of MST1R dysregulation in renal cell tumors.

Authors:  Ana S Pires-Luís; Márcia Vieira-Coimbra; Maria João Ferreira; João Ramalho-Carvalho; Pedro Costa-Pinheiro; Luís Antunes; Paula C Dias; Francisco Lobo; Jorge Oliveira; Inês Graça; Rui Henrique; Carmen Jerónimo
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

Review 5.  MSP-RON signalling in cancer: pathogenesis and therapeutic potential.

Authors:  Hang-Ping Yao; Yong-Qing Zhou; Ruiwen Zhang; Ming-Hai Wang
Journal:  Nat Rev Cancer       Date:  2013-07       Impact factor: 60.716

6.  Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men.

Authors:  J M Devaney; S Wang; P Furbert-Harris; V Apprey; M Ittmann; B-D Wang; J Olender; N H Lee; B Kwabi-Addo
Journal:  Epigenetics       Date:  2015-04-11       Impact factor: 4.528

7.  Preclinical Efficacy of Ron Kinase Inhibitors Alone and in Combination with PI3K Inhibitors for Treatment of sfRon-Expressing Breast Cancer Patient-Derived Xenografts.

Authors:  Magdalena Bieniasz; Parvathi Radhakrishnan; Najme Faham; Jean-Paul De La O; Alana L Welm
Journal:  Clin Cancer Res       Date:  2015-08-19       Impact factor: 12.531

Review 8.  Ron-receptor tyrosine kinase in tumorigenesis and metastasis.

Authors:  Mike A Leonis; Megan N Thobe; Susan E Waltz
Journal:  Future Oncol       Date:  2007-08       Impact factor: 3.404

9.  Recepteur d'Origine nantais (RON) tyrosine kinase splicing variants lacking exons 18 and 19 occur ubiquitously in lung cancer.

Authors:  Soundararajan Krishnaswamy; Abdul Khader Mohammed; Osama E Amer; Gyanendra Tripathi; Majed S Alokail; Nasser M Al-Daghri
Journal:  Int J Clin Exp Med       Date:  2015-11-15

10.  HRAS, EGFR, MET, and RON Genes Are Recurrently Activated by Provirus Insertion in Liver Tumors Induced by the Retrovirus Myeloblastosis-Associated Virus 2.

Authors:  Vladimir Pecenka; Petr Pajer; Vít Karafiat; Petra Kasparova; Jana Dudlova; Michal Dvorak
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.